






























































































































































CDC（Center for Disease Control and Prevention）が政
府を代表してアメリカの結核関係の頭脳を集め，結核撲



















































































































NTM＊＊ ８．３±３．９＊ ２８．７±２．７ ３１．１±１５．７
＊他の２法と比較して統計的に有意義（p＜０．０９５）
＊＊結核菌以外の抗酸菌（Nontuberculous mycobacteria）



































































































































































































































































































































用されている。それは“Knowing is not enough ; we must
apply. Willing is not enough ; we must do”.なんと的を得
た言葉だろうか。
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１９日本における結核対策の問題点
Problems associated with tuberculosis control in Japan
Tadayo Hashimoto, MD
Department of Microbiology and Immunology, Loyola University School of Medicine Maywood, IL 60153, USA
SUMMARY
Tuberculosis is the most prevalent infectious disease in the world. It occurs globally
but predominantly in developing countries where the standard of living is lagging behind
the industrialized nations. In Japan, tuberculosis was once the leading cause of death.
With the advent of medical sciences and the improved economic condition, the incidence of
tuberculosis in Japan started to decline after the World War II continuing until early 1970 s. It
was estimated that tuberculosis would become a disease of the past not in the far distant
future. However, this optimistic prediction was proved to be wrong. The continued decline
of tuberculosis cases in Japan was eventually replaced by increase in 1997. The subsequent
yearly increase of the disease prompted the government to declare the state of emergency
in the epidemic of tuberculosis. Clearly, the past policies and efforts to eliminate tuberculo-
sis have not been successful leaving tuberculosis largely uncontrolled in Japan. It is hard to
imagine that, despite a huge budget allocated to the tuberculosis elimination activities, the
incidence rate in Japan still remains close to those of developing countries.
The aims of this article are to describe and discuss the technical and administrative el-
ements impeding the progress of the tuberculosis elimination movement in Japan. Many
aspects of this article is based on the extensive personal experiences gained during visits to
many medical care facilities, clinical laboratories and professional society meetings both in
Japan and in the United States. It is also based on the candid discussion with professionals
engaging in tuberculosis control activities at grass root levels.
The first and foremost problem blocking the progress of the effective anti-tuberculosis
efforts in Japan is the lack of strong leadership by the government. There are no officially
published aims or guidelines for tuberculosis elimination programs. The priority of the tu-
berculosis elimination effort is unclear. Often, the government is not directly involved in the
tuberculosis elimination activities assigning its responsibilities to private or semi-government
agencies having no authorities to enforce key rules and regulations.
The diagnostic technologies currently employed by many clinical laboratories for the
diagnosis of tuberculosis is obsolete and outdated. Liquid culture systems now considered
globally as gold standard have not been widely used in Japan. Although it is partly due to
the lack of new knowledge on the part of laboratory technicians, the main reason for not
exploiting the merit of the globally tested and proved technologies is the unreasonably low
reimbursement for the test from Japanese health care insurance system. For detecting tu-
bercle bacilli in test specimens, most laboratories use the direct rather than concentrated method.
Because of the low sensitivity of the old tests, some active tuberculosis cases are feared
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undetected resulting in exposing the unsuspecting public to the risk of infection. It must be
also pointed out that many clinical laboratories sacrifice their safety for reducing operative
cost. The tuberculosis infection rate in the clinical laboratories is unacceptably high.
Misdiagnosis and delay in diagnosis by physicians due to negligence, ignorance, and out-
dated technologies contribute to the continued failure to eliminate infection source from the
Japanese society. A considerable numbers of diagnosed tuberculosis cases are not reported
to the authority as required by the anti-tuberculosis law, rendering contact tracing activities
and data gathering efforts difficult.
It is clear from a recent government survey that considerable numbers of diagnosed tu-
berculosis cases are not treated by the approved standard regimens. Treatment is often
initiated without susceptibility testing. DOTS (directly observed therapy short course) has
just began to be practiced in selected areas of Japan.
Last but not least, the effective progress of the tuberculosis elimination programs is se-
verely hindered by the use of funds on the basis of misplaced priority. The allocation of
budget does not seem to be made wisely based on the evidence-based data and real needs.
Rather, funds are being spent on a variety of programs already outdated or proved ineffec-
tive. Such examples include yearly screening and BCG inoculation stipulated by the
anti-tuberculosis law set about a half century ago. The need for change of the law is acute
and is widely supported by experts in and out of the country. However, such a move to change
the anti-tuberculosis law has met fierce resistance by bureaucratic and misguided profes-
sional.
It is believed that all factors mentioned above synergistically contribute to the frustrat-
ingly slow progress of the tuberculosis elimination movement in Japan. What Japan needs
now for the elimination of tuberculosis is not money, human resource, or knowledge. What
they need are willingness, determination and courage to do right things rather than sticking
to old customs and outdated practice. For this, strong and forceful leadership by the gov-
ernment is absolutely essential. Like defending the country, fighting against tuberculosis is
the responsibility of the government.
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egy impeding factors in tuberculosis control
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